Form 4: UnitedHealth Group Director Acquires Stock Units

Charles D. Baker, a Director at UnitedHealth Group, acquired 220 deferred stock units on July 1, 2026, as part of his regular quarterly compensation.

Summary

• Director Charles D. Baker acquired 220 deferred stock units (DSUs) on July 1, 2026.
• These DSUs were granted as part of his regular quarterly compensation for services as a director.
• The DSUs are immediately vested but must be held until completion of service on the Board.
• Following this transaction, Baker beneficially owns 2,396 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine director compensation and not a significant strategic or financial event.

Positives

• Director compensation is being paid in equity, aligning director interests with shareholders.
• The acquisition of DSUs indicates continued commitment from a key board member.

Risks

• Deferred stock units are subject to forfeiture if the director does not complete their service on the Board.
• The value of the acquired DSUs is subject to market fluctuations of UnitedHealth Group's stock price.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that equity-based compensation for directors is a common practice in the healthcare and managed care industry, aiming to align executive and director interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The transaction reinforces director alignment with shareholder interests through equity compensation.
• Directors: Charles D. Baker receives compensation in the form of deferred stock units.

Next Steps

• Director Charles D. Baker will retain the deferred stock units until completion of his service on the Board.

Key Dates

Keywords

UnitedHealth Group, UNH, Form 4, Director Compensation, Deferred Stock Units, Insider Transaction, Beneficial Ownership